Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
06/2009
06/25/2009WO2009061744A3 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
06/25/2009WO2009049961A3 New no-donor aspirin derivatives
06/25/2009WO2009017239A3 Process for producing toluidine compound
06/25/2009US20090163720 Condensing an enone with an alkylthioenamine, cyclizing in the presence of ammonia to form e.g. 5-(1-Methylthio)ethyl-2-(trifluoromethyl)pyridine high yield; intermediates for novel insecticides
06/25/2009US20090163558 Substituted Methyl Aryl or Heteroaryl Amide Compounds
06/25/2009US20090163556 Glycinamide derivatives as raf-kinase inhbitors
06/25/2009US20090163535 Substituted Heteroarylalkanoic Acids
06/25/2009US20090163515 Compounds Which Bind to the Active Site of Protein Kinase Enzymes
06/25/2009US20090163498 Aryl Sulfonamides
06/25/2009US20090163496 Antibacterial agents
06/25/2009US20090160326 Organic electroluminescence material and element using the same
06/25/2009CA2708324A1 Viral polymerase inhibitors
06/25/2009CA2708118A1 Mineralocorticoid receptor modulators
06/25/2009CA2707988A1 Novel pyrazole-substituted arylamides
06/24/2009EP2072501A1 Aminobenzamide derivatives as useful agents for controlling animal parasites
06/24/2009EP1781614B1 Compounds which potentiate glutamate receptor and uses thereof in medicine
06/24/2009EP1558567B1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds
06/24/2009CN101466678A Substituted 3-cyanopyridines as protein kinase inhibitors
06/24/2009CN101466677A Diaryl substituted alkanes
06/24/2009CN101466676A Pyridyl amide T-type calcium channel antagonists
06/24/2009CN101463004A Method for preparing isonicotinic acid by non-catalytic hydrolyzing isonicotinonitrile in near-critical water medium
06/24/2009CN100505377C Organic light emitting devices having carrier blocking layers comprising metal complexes
06/24/2009CN100503677C New catalysts for selective isocyanate dimerization
06/24/2009CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase
06/24/2009CN100503570C Cyanoguanidine prodrugs
06/23/2009US7550491 Ionic liquids having [N(CF3)2]− anions
06/23/2009US7550490 Cancer and psoriasis; e.g. N-(2-amino-4-fluorophenyl)-4-[N-(Pyridin-3-ylacryloyl)aminomethyl]benzamide
06/23/2009US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
06/23/2009US7550485 Conditions ameliorated by monoamine reuptake such as hot flashes, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders; e.g. 1-[2-(1,4'-bipiperidin-1'-yl)-1-(3-chlorophenyl)ethyl]cyclohexanol dihydrochloride
06/23/2009US7550481 Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's disease
06/23/2009US7550476 Condensed polycyclic compounds
06/23/2009US7550475 Use of phosphodiesterase 4 inhibitors such as 6,7-dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene to treat asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis
06/23/2009US7550474 Anticoagulants; strokes; restenosis; antiinflamamtory agents
06/23/2009US7550464 Use of phosphodiesterase 4 inhibitors such as 8,9-dimethoxy-6-phenyl-1,3,4,6,11,11a-hexahydro-2H -pyrazino[1,2-b]isoquinoline for treating asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis
06/23/2009US7550461 Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases
06/23/2009US7550457 Therapy of vascular system diseases
06/23/2009US7550456 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder
06/23/2009US7550246 Dissolving a pi complex of tetramethylcyclopentadienyl 2,2'-bipyridin-1,1'-diyl iridium hydride in a solvent; irrradiating with a laser beam to deprotonate and produce an acidicsolution; chemically-amplified photoresists; color filters for liquid rystal; photography/printing; solubility; efficiency
06/23/2009CA2504735C Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
06/23/2009CA2420694C Guanidinobenzamides as mc4-r agonists
06/23/2009CA2245080C Process for the preparation of heteroarylcarboxylic amides and esters
06/18/2009WO2009076142A2 Processes for producing cycloalkylcarboxiamido-pyridine benzoic acids
06/18/2009WO2009075874A1 Gamma secretase modulators
06/18/2009WO2009075112A1 Oxime ether derivative and bactericide for agricultural and horticultural use
06/18/2009WO2009075080A1 Fluoroalkylsulfide derivative and pest control agent
06/18/2009WO2009074749A2 Nicotinamide derivatives, preparation thereof and therapeutic use thereof
06/18/2009WO2009074594A1 Novel 2-ethyl-methyl-amino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
06/18/2009WO2009074593A1 Novel 2-pyrrolidinyl-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
06/18/2009WO2009074592A1 Novel 2-diethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
06/18/2009WO2009074591A1 Novel 2-dimethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
06/18/2009WO2009074019A1 Proteinase inhibitors useful for treating cancer
06/18/2009WO2009073943A1 Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (hica)
06/18/2009WO2009036996A3 Small molecule bradykinin b1 receptor antagonists
06/18/2009WO2009010296A3 Antibodies against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites thereof
06/18/2009WO2009010156A3 Substituted phenylpropoargyl compounds, methods for the production thereof, and use of same as herbicides and plant growth regulators
06/18/2009US20090158019 Computer Program Code Size Partitioning System for Multiple Memory Multi-Processing Systems
06/18/2009US20090156825 Fluorescent compounds that bind to histone deacetylase
06/18/2009US20090156803 Condensed furan compounds
06/18/2009US20090156685 (r)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity
06/18/2009US20090156646 Pyridylphenol compound and use thereof
06/18/2009US20090156624 Methionine aminopeptidase-2 inhibitors and methods of use thereof
06/18/2009US20090156616 Therapeutic agents
06/18/2009US20090156614 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof
06/18/2009US20090156578 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
06/18/2009US20090155203 Thrombopoietin mimetics
06/18/2009US20090153045 Platinum complex compound and organic electroluminescence device using the same
06/18/2009US20090153039 Green electroluminescent compounds and organic electroluminescent device using the same
06/18/2009CA2707494A1 Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
06/18/2009CA2707492A1 Gamma secretase modulators
06/18/2009CA2700559A1 Nicotinamide derivatives, preparation thereof and therapeutic use thereof
06/17/2009EP2070913A1 Ester derivatives as phosphodiesterase inhibitors
06/17/2009EP2070908A1 Compound having benzamide skeleton and cyclooxygenase (cox-1)-selective inhibitory activity
06/17/2009EP2069345A2 Pyridazine and pyrrole compounds, processes for obtaining them and uses
06/17/2009EP2069305A2 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
06/17/2009EP2069304A1 Improved electrochemical reduction of halogenated 4-aminopicolinic acids
06/17/2009EP2069303A2 Antiviral protease inhibitors
06/17/2009EP2069302A1 Substituted pyridylmethyl bicyclocarboxyamide compounds
06/17/2009EP2069291A1 Hdac inhibitors
06/17/2009EP2069289A1 ISOSERINE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS
06/17/2009EP2069287A1 Insecticidal compounds
06/17/2009EP2069286A1 Inhibitors for glyt-1
06/17/2009EP1789410B1 Methylene dipiperidine derivatives
06/17/2009EP1735345B1 Processes for preparing eptifibatide and pertinent intermediate compounds
06/17/2009EP1611088B1 Hydroxamates as therapeutic agents
06/17/2009EP1590341B1 2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation
06/17/2009EP1565431B1 Cannabinoid receptor ligands
06/17/2009EP1383736B1 Peptide deformylase inhibitors
06/17/2009CN101460463A Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
06/17/2009CN101456841A Amide derivative and medicine
06/17/2009CN100500679C Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage
06/17/2009CN100500655C Process for the separation of gaseous mixture products in chloro-pyridine compounds production
06/16/2009US7547802 Compounds for the treatment of metabolic disorders
06/16/2009US7547800 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
06/16/2009US7547782 Met kinase inhibitors
06/16/2009US7547731 Antiinflammatory agents; antiallergens; respiratory system disorders
06/16/2009US7547716 Sulfonamide derivatives
06/16/2009US7547714 (4 beta S,7R,8 alpha R)-4 beta -benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4 beta ,5,6,7,8,8 alpha ,9,10-octahydrophenanthrene-2-carboxamide; glucocorticoid receptor modulators; antiinflammatory agents; Alzheimer's disease
06/16/2009US7547713 O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives
06/16/2009US7547709 Prevent free radical cellular damage; oxidation resistant additive for fuels, lubricants, rubbers, polymers, solvents, chemical and foodstuff; lipid and water soluble vitamin c, vitamin e
06/16/2009US7547701 cathepsin S inhibitors; e.g. N-(1-cyanocyclopropyl)-3-phenylmethanesulfonyl-2-(2,2,2-trifluoro-1-phenylethylamino)-propionamide; autoimmune diseases such as rheumatoid arthritis or multiple sclerosis, pain, or atherosclerosis